Akèy › Kansè poumon selil ti › Maryland › Baltimore
Etid klinik pou Kansè poumon selil ti nan Baltimore, MD
11 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Ap rekriteFaz 3
- University of Maryland School of Medicine, Baltimore
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Ap rekriteFaz 1/2
- United Theranostics, Glen Burnie · 9 mi lwen
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- University of Maryland, Baltimore
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Ap rekriteFaz 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Ap rekriteFaz 2
- University of Maryland School of Medicine, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Ap rekriteFaz 1/2
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Ap rekriteEtid obsèvasyon
- Johns Hopkins University, Baltimore
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Ap rekriteFaz 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Ap rekriteFaz 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Etid Kansè poumon selil ti nan lòt vil
- Houston, TX26 etid
- Arlington, VA23 etid
- Boston, MA21 etid
- New York City, NY21 etid
- Nashville, TN20 etid
- Los Angeles, CA20 etid
- Orlando, FL15 etid
- Dallas, TX13 etid
- St. Louis, MO13 etid
- Cleveland, OH13 etid
- Detroit, MI12 etid
- Chicago, IL12 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.